Osaic Holdings
SLS icon

Osaic Holdings’s SELLAS Life Sciences SLS Stock Holding History

Osaic Holdings’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$687K Sell
56,553
-3,731
-6% -$46.7K ﹤0.01% 3347
2026
Q2 		$890K Buy
60,284
+13,012
+28% +$89.8K ﹤0.01% 3126
2026
Q1 		$200K Buy
47,272
+23,583
+100% +$106K ﹤0.01% 4137
2025
Q4 		$89.3K Buy
23,689
+16,029
+209% +$31.2K ﹤0.01% 4806
2025
Q3 		$14.7K Hold
7,660
– – ﹤0.01% 6131
2025
Q2 		$16.8K Buy
7,660
+5,000
+188% +$7.67K ﹤0.01% 5838
2025
Q1 		$2.87K Buy
2,660
+1,000
+60% +$1.19K ﹤0.01% 6452
2024
Q4 		$1.73K Hold
1,660
– – ﹤0.01% 6661
2024
Q3 		$2.08K Hold
1,660
– – ﹤0.01% 6595
2024
Q2 		$1.98K Hold
1,660
– – ﹤0.01% 6598
2024
Q1 		$1.68K Hold
1,660
– – ﹤0.01% 6537
2023
Q4 		$1.76K Sell
1,660
-1,660
-50% -$1.8K ﹤0.01% 6579
2023
Q3 		$5.44K Buy
3,320
+1,660
+100% +$2.62K ﹤0.01% 6231
2023
Q2 		$2.61K Hold
1,660
– – ﹤0.01% 6570
2023
Q1 		$2.37K Hold
1,660
– – ﹤0.01% 6645
2022
Q4 		$4K Sell
1,660
-5
-0.3% -$14 ﹤0.01% 6426
2022
Q3 		$3K Sell
1,665
-200
-11% -$552 ﹤0.01% 6662
2022
Q2 		$4K Buy
1,865
+1,000
+116% +$2.93K ﹤0.01% 6628
2022
Q1 		$5K Hold
865
– – ﹤0.01% 6501
2021
Q4 		$5K Sell
865
-1,215
-58% -$9.19K ﹤0.01% 6654
2021
Q3 		$19K Buy
2,080
+500
+32% +$4.64K ﹤0.01% 5825
2021
Q2 		$17K Buy
1,580
+205
+15% +$2K ﹤0.01% 5763
2021
Q1 		$11K Buy
1,375
+1,065
+344% +$8.71K ﹤0.01% 5830
2020
Q4 		$2K Buy
310
+150
+94% +$600 ﹤0.01% 6105
2020
Q3 		$0 Hold
160
– – ﹤0.01% 6388
2020
Q2 		$0 Hold
160
– – ﹤0.01% 6305
2020
Q1 		$0 Buy
+160
New +$412 ﹤0.01% 6169

Other funds holding SLS

State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
DI
DAGCO Inc Westlake, Ohio $576M AUM 21.79% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $73.3B AUM 63.67% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Opus Capital Group
Opus Capital Group Cincinnati, Ohio $1.02B AUM 13.75% 1-Year Est. Return
Swiss National Bank
Swiss National Bank Zurich, Switzerland $189B AUM 37.1% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return

Osaic Holdings's SLS Position: Q3 2026 in Review

Osaic Holdings reduced its SELLAS Life Sciences (SLS) stake by 6.2% in Q3 2026, selling an estimated $46.7K and leaving 56,553 shares worth $687K. The position accounts for ﹤0.01% of the portfolio, ranked #3347.

Osaic Holdings first reported a position in SLS in Q1 2020 and has held it in 27 quarters since. The position peaked at $890K in Q2 2026. 133 funds tracked by Wall St. Rank hold SLS as of Q3 2026.

  • Osaic Holdings held 56,553 shares of SELLAS Life Sciences worth $687K as of Q3 2026.
  • Osaic Holdings sold 3,731 SELLAS Life Sciences shares in Q3 2026, an estimated $46.7K.
  • SELLAS Life Sciences made up ﹤0.01% of Osaic Holdings's portfolio in Q3 2026, its #3347 holding.
  • Osaic Holdings first reported a position in SELLAS Life Sciences in Q1 2020 and has held it in 27 quarters since.
  • Osaic Holdings's SELLAS Life Sciences position peaked at $890K in Q2 2026.
  • 133 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q3 2026.

Based on Osaic Holdings's 13F filing for Q3 2026, filed 12 Nov 2026.